This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Myriad Genetics appoints Raj Jampa CTO
Business executive appointment

Myriad Genetics appoints Raj Jampa CTO

Analysis based on 6 articles · First reported Jun 02, 2026 · Last updated Jun 02, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The appointment of Raj Jampa as CTO is viewed positively for Myriad Genetics, as his expertise in technology and AI is expected to drive innovation and growth, potentially leading to an increase in the company's stock price. The market's initial reaction showed a slight dip in pre-market trading, but the long-term impact is anticipated to be beneficial for Myriad Genetics.

Biotechnology Healthcare
Event Summary

Myriad Genetics, a leader in molecular diagnostic testing and precision medicine, announced the appointment of Raj Jampa as its new Chief Technology Officer, effective June 1, 2026. Raj Jampa will be responsible for the strategy and execution of Myriad's technology organization, with a focus on leveraging AI to enhance efficiency and effectiveness. Myriad Genetics CEO, Sam Raha, stated that Raj Jampa's leadership will be crucial in strengthening the company's digital technology foundation, improving customer experience, and supporting its next phase of growth and value creation. Raj Jampa brings extensive experience from previous senior technology leadership roles at General Atomics, Exact sciences, and Exact Sciences — Genomic Health, where he led large-scale transformation initiatives.

Entities Involved
stock
Myriad Genetics
Myriad Genetics appointed Raj Jampa as its new Chief Technology Officer, aiming to strengthen its digital technology foundation, enhance customer experience, and support future growth and value creation. This appointment is expected to modernize its technology infrastructure and scale AI-enabled capabilities.
Importance 100.0 Sentiment 10.0
per
Raj Jampa
Raj Jampa was appointed Chief Technology Officer of Myriad Genetics. He will be responsible for strategy and execution of Myriad's technology organization, including leveraging AI to drive efficiency and effectiveness. His prior experience is expected to help advance Myriad's growth strategy.
Importance 90.0 Sentiment 20.0
per
Sam Raha
Sam Raha, CEO of Myriad Genetics, announced the appointment of Raj Jampa, highlighting his vision and experience as instrumental for the company's technology innovation and growth.
Importance 30.0 Sentiment 0.0
subs
Exact Sciences — Genomic Health
Raj Jampa previously held senior technology leadership roles at Exact Sciences — Genomic Health, where he led large-scale transformation initiatives.
Importance 10.0 Sentiment 0.0
stock
Exact sciences
Raj Jampa previously held senior technology leadership roles at Exact sciences, contributing to his experience in large-scale transformation initiatives.
Importance 10.0 Sentiment 0.0
priv
General Atomics
Raj Jampa previously held senior technology leadership roles at General Atomics, gaining experience relevant to his new role at Myriad Genetics.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.